Anthony B. Evnin, Director at INFINITY PHARMACEUTICALS, INC. (INFI), sold 17,756 shares at $14.56 ($259K) on 2013-12-02, disclosed to the SEC on 2013-12-04.
Open-market sale of $259k INFI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CNST | BUY | 2019-10-04 | $48.0M | — | Filing → |
| AVEO | BUY | 2018-11-26 | $223 | — | Filing → |
| AVEO | SELL | 2018-11-16 | $4.3M | — | Filing → |